Aggarwal Shruti, Dhaliwal Jasninder Singh, Kumar Nomesh, Sakthivel Hemamalini, Ahmed Raheel, Verma Renuka, Ramphul Kamleshun
Guru Gobind Singh Medical College, Sadiq Road, Faridkot, India.
Department of Internal Medicine, University of California, Riverside, United States.
Reumatologia. 2024;62(3):214-216. doi: 10.5114/reum/189213. Epub 2024 Jun 7.
During the pandemic of COVID-19, a novel atypical set of clinical findings was seen among several children with recent or current exposure to the virus. It was termed the "multisystem inflammatory syndrome in children" (MIS-C). Our study used the 2021 National Inpatient Sample to study the associations of sex, race, and age with the incidence of MIS-C among COVID-19-positive children. Out of 69,440 COVID-19-positive children, 2,790 (4.0%) reported MIS-C. The incidence of MIS-C was highest among those aged 8 years old (17,130 MIS-C cases per 100,000 COVID-19 patients), Asian or Pacific Islanders (API) (5,346 MIS-C per 100,000 COVID-19 cases), and males (4,734 cases per 100,000 COVID-19 cases). Furthermore, 7.9% of MIS-C cases met the classification of Kawasaki disease.
在新冠疫情期间，在近期或当前接触过该病毒的几名儿童中发现了一组新的非典型临床症状。它被称为“儿童多系统炎症综合征”（MIS-C）。我们的研究使用了2021年全国住院患者样本，以研究性别、种族和年龄与新冠病毒检测呈阳性儿童中MIS-C发病率之间的关联。在69440名新冠病毒检测呈阳性的儿童中，2790名（4.0%）报告患有MIS-C。MIS-C的发病率在8岁儿童中最高（每10万名新冠患者中有17130例MIS-C病例），在亚裔或太平洋岛民（API）中最高（每10万例新冠病例中有5346例MIS-C），在男性中最高（每10万例新冠病例中有4734例）。此外，7.9%的MIS-C病例符合川崎病的分类。
